News
FDA Approves PrEP Drug Requiring Only Two Injections Per Year
Like other PrEP drugs, if enough of the medication is present when a person is exposed to HIV, it can prevent the virus from taking hold and causing a lifelong infection. Because lenacapavir is long-acting, it requires only two injections per year.
The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...
Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...
The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...
While Gilead Sciences' HIV prevention drug lenacapavir got approved by the US Food and Drug Administration (FDA), its made- ...
The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...
Audacy on MSN22h
There's a new, highly effective HIV drug on the marketA revolutionary new preventative medicine that protects against the HIV virus has just been approved by the U.S. Food and ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
The recent FDA approval of lenacapavir is encouraging in its promise of long-term HIV prevention but might not be available for the vast majority of people in the US.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback